Your browser doesn't support javascript.
loading
Validity and Reliability of the New Chinese Version of the Frontal Assessment Battery-Phonemic.
Li, Xudong; Shen, Miaoxin; Jin, Yi; Jia, Shuhong; Zhou, Zhi; Han, Ziling; Zhang, Xiangfei; Tong, Xiaopeng; Jiao, Jinsong.
Afiliação
  • Li X; Department of Cognitive Disorder, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Shen M; China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Jin Y; Medical School, Xizang Minzu University, Xianyang, China.
  • Jia S; Department of Neurology, China-Japan Friendship Hospital, Beijing, China.
  • Zhou Z; Department of Neurology, China-Japan Friendship Hospital, Beijing, China.
  • Han Z; Department of Neurology, China-Japan Friendship Hospital, Beijing, China.
  • Zhang X; Department of Cognitive Disorder, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Tong X; Department of Neurology, China-Japan Friendship Hospital, Beijing, China.
  • Jiao J; Medical School, Xizang Minzu University, Xianyang, China.
J Alzheimers Dis ; 80(1): 371-381, 2021.
Article em En | MEDLINE | ID: mdl-33554904
BACKGROUND: Alzheimer's disease dementia (ADD) is an important health problem in the world. OBJECTIVE: The present study investigated the validity and reliability of a new version of the Frontal Assessment Battery (FAB) named the FAB-phonemic (FAB-P). METHODS: A total of 76 patients with ADD, 107 patients with amnestic mild cognitive impairment (aMCI), 37 patients with non-amnestic MCI (naMCI), and 123 healthy controls were included in this study. All participants were evaluated with the FAB-P and the cognitive assessments according to a standard procedure. RESULTS: The global FAB-P scores in patients with ADD were lower than those of patients with aMCI, patients with naMCI, and healthy controls (p < 0.001). Patients with aMCI performed worse than healthy controls (p < 0.001). The interrater reliability, test-retest reliability, and Cronbach's alpha coefficient for the FAB-P were 0.997, 0.819, and 0.736, respectively. The test could distinguish the patients with mild ADD, aMCI, and naMCI from healthy controls with classification accuracy of 89.4%, 70.9%, and 61.6%, respectively. It could also discriminate between the patients with ADD and aMCI, between those with ADD and naMCI, and between those with aMCI and naMCI with classification accuracy of 73.8%, 83.9%, and 58.0%, respectively. The regression analysis revealed that the Montreal Cognitive Assessment and the Stroop Color Word Test Part C had the greatest contribution to FAB-P score variance. CONCLUSION: The FAB-P is a valid and reliable tool for evaluating frontal lobe function and can effectively discriminate ADD, aMCI, and naMCI.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva / Lobo Frontal / Testes Neuropsicológicos Tipo de estudo: Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva / Lobo Frontal / Testes Neuropsicológicos Tipo de estudo: Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article